Advances in Antiviral Drug Design
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 0)

H-INDEX

(FIVE YEARS 0)

Published By Elsevier

9780444521736

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

CCR5 antagonists for the treatment of HIV infection and AIDS

Advances in Antiviral Drug Design ◽

10.1016/s1075-8593(06)05005-2 ◽

2007 ◽

pp. 185-212 ◽

Cited By ~ 10

Author(s):

Manos Perros

Keyword(s):

Hiv Infection ◽

Ccr5 Antagonists

The medicinal chemistry of the DATA and DAPY series of HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs)

Advances in Antiviral Drug Design ◽

10.1016/s1075-8593(06)05006-4 ◽

2007 ◽

pp. 213-242 ◽

Cited By ~ 21

Author(s):

Jan Heeres ◽

Paul J. Lewi

Keyword(s):

Reverse Transcriptase ◽

Medicinal Chemistry ◽

Reverse Transcriptase Inhibitors ◽

Nucleoside Reverse Transcriptase Inhibitors ◽

Hiv 1

Synthesis and antiviral evaluation of broad spectrum, orally active analogs of cidofovir and other acyclic nucleoside phosphonates

Advances in Antiviral Drug Design ◽

10.1016/s1075-8593(06)05004-0 ◽

2007 ◽

pp. 167-184 ◽

Cited By ~ 5

Author(s):

Karl Y. Hostetler

Keyword(s):

Broad Spectrum ◽

Acyclic Nucleoside Phosphonates ◽

Acyclic Nucleoside ◽

Orally Active

Advances in Antiviral Drug Design ◽

10.1016/s1075-8593(06)05007-6 ◽

2007 ◽

pp. v

Methylenecyclopropane Analogues of Nucleosides as Anti-herpes Agents

Advances in Antiviral Drug Design ◽

10.1016/s1075-8593(06)05003-9 ◽

2007 ◽

pp. 113-165 ◽

Cited By ~ 13

Author(s):

Jiri Zemlicka

List of Contributors

Advances in Antiviral Drug Design ◽

10.1016/s1075-8593(06)05009-x ◽

2007 ◽

pp. vii

Index

Advances in Antiviral Drug Design ◽

10.1016/s1075-8593(06)05008-8 ◽

2007 ◽

pp. 243-251

Status Presens of Antiviral Drugs And Strategies: Part I: DNA Viruses and Retroviruses

Advances in Antiviral Drug Design ◽

10.1016/s1075-8593(06)05001-5 ◽

2007 ◽

pp. 1-58 ◽

Cited By ~ 2

Author(s):

Erik De Clercq

Keyword(s):

Antiviral Drugs ◽

Dna Viruses

Preface

Advances in Antiviral Drug Design ◽

10.1016/s1075-8593(06)05010-6 ◽

2007 ◽

pp. ix-xi

Author(s):

E. De Clercq

Status presens of antiviral drugs and strategies: Part II: RNA VIRUSES (EXCEPT RETROVIRUSES)

Advances in Antiviral Drug Design ◽

10.1016/s1075-8593(06)05002-7 ◽

2007 ◽

pp. 59-112 ◽

Cited By ~ 1

Author(s):

Erik De Clercq

Keyword(s):

Rna Viruses ◽

Antiviral Drugs

Advances in Antiviral Drug Design
Latest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Elsevier

CCR5 antagonists for the treatment of HIV infection and AIDS

The medicinal chemistry of the DATA and DAPY series of HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs)

Synthesis and antiviral evaluation of broad spectrum, orally active analogs of cidofovir and other acyclic nucleoside phosphonates

Contents

Methylenecyclopropane Analogues of Nucleosides as Anti-herpes Agents

List of Contributors

Index

Status Presens of Antiviral Drugs And Strategies: Part I: DNA Viruses and Retroviruses

Preface

Status presens of antiviral drugs and strategies: Part II: RNA VIRUSES (EXCEPT RETROVIRUSES)

Export Citation Format

Advances in Antiviral Drug DesignLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Elsevier

CCR5 antagonists for the treatment of HIV infection and AIDS

The medicinal chemistry of the DATA and DAPY series of HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs)

Synthesis and antiviral evaluation of broad spectrum, orally active analogs of cidofovir and other acyclic nucleoside phosphonates

Contents

Methylenecyclopropane Analogues of Nucleosides as Anti-herpes Agents

List of Contributors

Index

Status Presens of Antiviral Drugs And Strategies: Part I: DNA Viruses and Retroviruses

Preface

Status presens of antiviral drugs and strategies: Part II: RNA VIRUSES (EXCEPT RETROVIRUSES)

Advances in Antiviral Drug Design
Latest Publications